Some U.S. drugmakers still see benefit of being in vaccine business

10/29/2004 | NYTimes.com

Despite recent shortages of flu vaccine, some pharmaceutical manufacturers believe making vaccines is still a good business. Several U.S. drugmakers are actively developing new vaccines for diseases ranging from infections obtained in kidney dialysis centers to viruses that cause ebola, West Nile and SARS to pneumococcal-caused diseases.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC